Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis (Q34580943)

3 August 2017

0 references

1 reference

title

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis (English)

1 reference

3 August 2017

0 references

0 references

1 reference

0 references

Marina T van Leeuwen

2

0 references

Michael Falster

object named as

Michael O Falster

series ordinal

3

0 references

Claire Melissa Vajdic

object named as

Claire M Vajdic

series ordinal

4

0 references

author name string

Andrew E Grulich

series ordinal

1

1 reference

PubMed ID

17617273

3 August 2017

language of work or name

English

0 references

publication date

1 July 2007

1 reference

3 August 2017

1 reference

3 August 2017

370

1 reference

3 August 2017

59-67

1 reference

3 August 2017

9581

1 reference

Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Association of Cancer With AIDS-Related Immunosuppression in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Cancer incidence before and after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Cancer Incidence Among Canadian Kidney Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Trends in cancer risk among people with AIDS in the United States 1980-2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Risk of cancer in persons with AIDS in Italy, 1985-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

The global health burden of infection-associated cancers in the year 2002

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Incidence of malignant neoplasms among HIV-infected persons in Scotland.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

The risk of cancer in HIV-infected people in southeast England: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Cancer risk in patients on dialysis and after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Cancer incidence in a kidney-transplanted population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Cancer risk following organ transplantation: a nationwide cohort study in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Kaposi's sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Carcinogenicity of human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Infections and immune factors in cancer: the role of epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Chapter 9: Role of mucosal human papillomavirus in nongenital cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Combination antiretroviral therapy and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Kaposi's sarcoma-associated herpesvirus: a sexually transmissible infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961050-2

7 January 2021

10.1016/S0140-6736(07)61050-2

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

17617273